Selected research
Industry Research
Domperidone Industry Research Report 2026
Market perspective
The global Domperidone market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Domperidone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Domperidone is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Domperidone is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Domperidone include Xian Janssen Pharmaceutical, Lizhu Pharmaceutical Group, Jiangxi Jiezhong Biochemistry, Jiangxi Huiren Pharmaceutical, Hunan Qianjin Xiangjiang, Hainan Asia Pharmaceutical, Foshan Shouxin Pharmaceutical, Shreeji Pharma International and Schwitz Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Domperidone market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Domperidone Market by Company
Xian Janssen Pharmaceutical
Lizhu Pharmaceutical Group
Jiangxi Jiezhong Biochemistry
Jiangxi Huiren Pharmaceutical
Hunan Qianjin Xiangjiang
Hainan Asia Pharmaceutical
Foshan Shouxin Pharmaceutical
Shreeji Pharma International
Schwitz Biotech
Meenaxy Pharma Pvt. Ltd
Luckys Pharma
Domperidone Segment by Type
Tablets
Pellets
Other
Domperidone Segment by Application
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Domperidone Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Domperidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Domperidone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Domperidone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Domperidone manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Domperidone by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Domperidone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets
- Pellets
- Other
Applications
- Retail Pharmacies
- Online Pharmacies
- Hospital Pharmacies
Companies covered
- Xian Janssen Pharmaceutical
- Lizhu Pharmaceutical Group
- Jiangxi Jiezhong Biochemistry
- Jiangxi Huiren Pharmaceutical
- Hunan Qianjin Xiangjiang
- Hainan Asia Pharmaceutical
- Foshan Shouxin Pharmaceutical
- Shreeji Pharma International
- Schwitz Biotech
- Meenaxy Pharma Pvt. Ltd
- Luckys Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Domperidone Market Size (2021-2032)
- 2.2.2 Global Domperidone Sales (2021-2032)
- 2.2.3 Global Domperidone Market Average Price (2021-2032)
- 2.3 Domperidone by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablets
- 2.3.3 Pellets
- 2.3.4 Other
- 2.4 Domperidone by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Retail Pharmacies
- 2.4.3 Online Pharmacies
- 2.4.4 Hospital Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Domperidone Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Domperidone Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Domperidone Revenue of Manufacturers (2021-2026)
- 3.4 Global Domperidone Average Price by Manufacturers (2021-2026)
- 3.5 Global Domperidone Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Domperidone, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Domperidone, Product Type & Application
- 3.8 Global Manufacturers of Domperidone, Established Date
- 3.9 Global Domperidone Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Xian Janssen Pharmaceutical
- 4.1.1 Xian Janssen Pharmaceutical Company Information
- 4.1.2 Xian Janssen Pharmaceutical Business Overview
- 4.1.3 Xian Janssen Pharmaceutical Domperidone Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Xian Janssen Pharmaceutical Domperidone Product Portfolio
- 4.1.5 Xian Janssen Pharmaceutical Recent Developments
- 4.2 Lizhu Pharmaceutical Group
- 4.2.1 Lizhu Pharmaceutical Group Company Information
- 4.2.2 Lizhu Pharmaceutical Group Business Overview
- 4.2.3 Lizhu Pharmaceutical Group Domperidone Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Lizhu Pharmaceutical Group Domperidone Product Portfolio
- 4.2.5 Lizhu Pharmaceutical Group Recent Developments
- 4.3 Jiangxi Jiezhong Biochemistry
- 4.3.1 Jiangxi Jiezhong Biochemistry Company Information
- 4.3.2 Jiangxi Jiezhong Biochemistry Business Overview
- 4.3.3 Jiangxi Jiezhong Biochemistry Domperidone Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Jiangxi Jiezhong Biochemistry Domperidone Product Portfolio
- 4.3.5 Jiangxi Jiezhong Biochemistry Recent Developments
- 4.4 Jiangxi Huiren Pharmaceutical
- 4.4.1 Jiangxi Huiren Pharmaceutical Company Information
- 4.4.2 Jiangxi Huiren Pharmaceutical Business Overview
- 4.4.3 Jiangxi Huiren Pharmaceutical Domperidone Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Jiangxi Huiren Pharmaceutical Domperidone Product Portfolio
- 4.4.5 Jiangxi Huiren Pharmaceutical Recent Developments
- 4.5 Hunan Qianjin Xiangjiang
- 4.5.1 Hunan Qianjin Xiangjiang Company Information
- 4.5.2 Hunan Qianjin Xiangjiang Business Overview
- 4.5.3 Hunan Qianjin Xiangjiang Domperidone Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hunan Qianjin Xiangjiang Domperidone Product Portfolio
- 4.5.5 Hunan Qianjin Xiangjiang Recent Developments
- 4.6 Hainan Asia Pharmaceutical
- 4.6.1 Hainan Asia Pharmaceutical Company Information
- 4.6.2 Hainan Asia Pharmaceutical Business Overview
- 4.6.3 Hainan Asia Pharmaceutical Domperidone Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Hainan Asia Pharmaceutical Domperidone Product Portfolio
- 4.6.5 Hainan Asia Pharmaceutical Recent Developments
- 4.7 Foshan Shouxin Pharmaceutical
- 4.7.1 Foshan Shouxin Pharmaceutical Company Information
- 4.7.2 Foshan Shouxin Pharmaceutical Business Overview
- 4.7.3 Foshan Shouxin Pharmaceutical Domperidone Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Foshan Shouxin Pharmaceutical Domperidone Product Portfolio
- 4.7.5 Foshan Shouxin Pharmaceutical Recent Developments
- 4.8 Shreeji Pharma International
- 4.8.1 Shreeji Pharma International Company Information
- 4.8.2 Shreeji Pharma International Business Overview
- 4.8.3 Shreeji Pharma International Domperidone Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Shreeji Pharma International Domperidone Product Portfolio
- 4.8.5 Shreeji Pharma International Recent Developments
- 4.9 Schwitz Biotech
- 4.9.1 Schwitz Biotech Company Information
- 4.9.2 Schwitz Biotech Business Overview
- 4.9.3 Schwitz Biotech Domperidone Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Schwitz Biotech Domperidone Product Portfolio
- 4.9.5 Schwitz Biotech Recent Developments
- 4.10 Meenaxy Pharma Pvt. Ltd
- 4.10.1 Meenaxy Pharma Pvt. Ltd Company Information
- 4.10.2 Meenaxy Pharma Pvt. Ltd Business Overview
- 4.10.3 Meenaxy Pharma Pvt. Ltd Domperidone Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Meenaxy Pharma Pvt. Ltd Domperidone Product Portfolio
- 4.10.5 Meenaxy Pharma Pvt. Ltd Recent Developments
- 4.11 Luckys Pharma
- 4.11.1 Luckys Pharma Company Information
- 4.11.2 Luckys Pharma Business Overview
- 4.11.3 Luckys Pharma Domperidone Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Luckys Pharma Domperidone Product Portfolio
- 4.11.5 Luckys Pharma Recent Developments
5 Global Domperidone Market Scenario by Region
- 5.1 Global Domperidone Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Domperidone Sales by Region: 2021-2032
- 5.2.1 Global Domperidone Sales by Region: 2021-2026
- 5.2.2 Global Domperidone Sales by Region: 2027-2032
- 5.3 Global Domperidone Revenue by Region: 2021-2032
- 5.3.1 Global Domperidone Revenue by Region: 2021-2026
- 5.3.2 Global Domperidone Revenue by Region: 2027-2032
- 5.4 North America Domperidone Market Facts & Figures by Country
- 5.4.1 North America Domperidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Domperidone Sales by Country (2021-2032)
- 5.4.3 North America Domperidone Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Domperidone Market Facts & Figures by Country
- 5.5.1 Europe Domperidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Domperidone Sales by Country (2021-2032)
- 5.5.3 Europe Domperidone Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Domperidone Market Facts & Figures by Country
- 5.6.1 Asia Pacific Domperidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Domperidone Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Domperidone Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Domperidone Market Facts & Figures by Country
- 5.7.1 South America Domperidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Domperidone Sales by Country (2021-2032)
- 5.7.3 South America Domperidone Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Domperidone Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Domperidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Domperidone Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Domperidone Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Domperidone Sales by Type (2021-2032)
- 6.1.1 Global Domperidone Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Domperidone Sales Market Share by Type (2021-2032)
- 6.2 Global Domperidone Revenue by Type (2021-2032)
- 6.2.1 Global Domperidone Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Domperidone Revenue Market Share by Type (2021-2032)
- 6.3 Global Domperidone Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Domperidone Sales by Application (2021-2032)
- 7.1.1 Global Domperidone Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Domperidone Sales Market Share by Application (2021-2032)
- 7.2 Global Domperidone Revenue by Application (2021-2032)
- 7.2.1 Global Domperidone Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Domperidone Revenue Market Share by Application (2021-2032)
- 7.3 Global Domperidone Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Domperidone Value Chain Analysis
- 8.1.1 Domperidone Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Domperidone Production Mode & Process
- 8.2 Domperidone Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Domperidone Distributors
- 8.2.3 Domperidone Customers
9 Global Domperidone Analyzing Market Dynamics
- 9.1 Domperidone Industry Trends
- 9.2 Domperidone Industry Drivers
- 9.3 Domperidone Industry Opportunities and Challenges
- 9.4 Domperidone Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst